Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Guidelines are continuing to evolve to meet the changing landscape of cancer and the new technologies available to find and treat it.
New tech is giving scientists unprecedented insights into single cells’ inner workings.
The risk is highest following pancreatic and lung cancer diagnoses.
New UCSF study analyzes prostate cancer deaths by race.
Cancer mortality declined by 27 percent over the past 25 years.
Growing cells in solutions that don’t properly mimic animal cells could be skewing results.
The CDC reports widespread flu activity in 24 states.
The American territory also does not cover liver transplants for sick people.
The singer is currently battling metastatic breast cancer.
Older drugs, many on the market for years, are rising in cost much faster than inflation.
Members of “help insurance” groups accompany one another to appointments, support each other through medical treatment and share informati...
Researchers propose using a less-than-one-in-a-million level—or the absence of minimal residual disease—to measure drugs’ effectiveness.
The benefits? Risk is assessed more rapidly and at a cheaper cost.
However, the study showed that psychological distress was not a strong predictor of cancer.
Four out of 10 FDA workers are sidelined.
These drugs, made from living organisms, are big moneymakers partly because they have little competition. It’s a different story in Europe.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.